molecule_chembl_id,canonical_smiles,standard_value,standard_units,standard_type,target_pref_name,target_organism,activity_comment,assay_description,document_journal,document_year
CHEMBL311039,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),J Med Chem,2000
CHEMBL450926,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),J Med Chem,2000
CHEMBL310242,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,1800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),J Med Chem,2000
CHEMBL74874,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,11000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),J Med Chem,2000
CHEMBL75183,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),J Med Chem,2000
CHEMBL563,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,305000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196279,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,75000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL195970,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,77000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL195970,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,94000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide,J Med Chem,2005
CHEMBL264006,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,21000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL264006,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,46000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide,J Med Chem,2005
CHEMBL193971,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,129000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL194274,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,83000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196321,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,67000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196322,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,210000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL380778,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,41000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL197202,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,35000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL194760,O=C(O)C1(c2ccc(-c3ccccc3)c(F)c2)CC1,-1,%,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide,J Med Chem,2005
CHEMBL196246,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,111000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196246,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,22000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 um,J Med Chem,2005
CHEMBL196945,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,41000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196945,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,14000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL196946,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,96300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196946,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,-5,%,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL372751,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,46000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL372751,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,101000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL194692,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,70600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196947,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,31600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196947,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,409000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL372846,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,33600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL372846,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,111000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide,J Med Chem,2005
CHEMBL427548,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,57900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL197140,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,11000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL382721,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,81000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide,J Med Chem,2005
CHEMBL436483,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,17700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL196070,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,114000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL193900,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,64000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL193900,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,12000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL194020,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Concentration required to inhibit A beta 40 peptide 100 uM,J Med Chem,2005
CHEMBL190083,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,280000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),J Med Chem,2005
CHEMBL200116,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](O)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,6700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL199946,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,5.2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL202877,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,6000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL425031,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](O)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL200014,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,9900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL202507,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,740,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL200077,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,J Med Chem,2006
CHEMBL204357,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL206766,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1=O,6800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL204443,CCC[C@H](C(=O)NC/C=C/Cc1ccccc1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL381336,CCC[C@H](C(=O)NC1CCCC1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,6000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL205400,CCC[C@H](C(=O)NCc1ccco1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL205714,CCCCNC(=O)[C@@H](CCC)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL208230,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(NN3CCCCC3)c2)C1=O,74,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL424684,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(C(F)(F)F)cc3)c2)C1=O,30,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL274414,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(OC)cc3)c2)C1=O,160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL208504,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(F)c(Cl)c3)c2)C1=O,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL205970,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc4c(c3)OCO4)c2)C1=O,152,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL410532,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(OC)c3)c2)C1=O,54,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL208350,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(C)c3)c2)C1=O,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL382880,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3Cl)c2)C1=O,29,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL205907,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3)c2)C1=O,15,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta-amyloid peptide production in CHO N9 cell line,Bioorg Med Chem Lett,2006
CHEMBL231446,CN1CCCC1CCNC(=O)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,530,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL396543,O=C(OC[C@H]1CCC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,16,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231548,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231547,O=C(NC1CCN(Cc2ccccc2)CC1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231449,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231448,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL396542,CN1CCN(C(=O)OC[C@H]2CC[C@@H](c3ccccc3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1,450,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231351,O=C(NCCCn1ccnc1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,650,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL395313,CN1CCCC1CCNC(=O)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231250,O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,73,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231248,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,60,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL395312,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,360,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL390889,O=C(NC1CCN(Cc2ccccc2)CC1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,190,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231647,O=C(NC1CCN(Cc2ccccc2)CC1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231545,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231035,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL230931,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,680,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL425304,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,880,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231125,CN1CCN(C(=O)OCCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,780,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL390478,CN1CCN(C(=O)OCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231544,O=C(NCCCn1ccnc1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,86,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL389549,O=C(NCCCn1ccnc1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,280,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL231447,CN1CCCC1CCNC(=O)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,220,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase,Bioorg Med Chem Lett,2007
CHEMBL240055,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,0.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240286,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,56,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240285,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,47,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL398395,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,46,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240284,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240071,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240070,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL240069,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,27,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL442801,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,3.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL239859,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL239858,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,2.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL400420,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,2.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL239629,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,2.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL393941,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236192,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,16,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL429448,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,29,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236191,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,81,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236190,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,6.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236189,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,27,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236188,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,9.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236187,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,16,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236186,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)cc1,25,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236185,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,10,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392060,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236184,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,6.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236183,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392059,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236182,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,13,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL394132,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL238271,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,28,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392144,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236196,CCC1(O)CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,104,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL429449,CC(C)(CO)N1CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,57,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236195,O=C(O[C@@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,2425,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236193,O=C(O[C@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,15,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392144,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,4.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL393941,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,39,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236192,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL429448,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,144,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236190,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,45,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236188,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,20,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236187,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,115,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236185,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,25,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392060,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,7.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236184,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,8.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236183,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,15,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392059,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL236182,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,10,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL394132,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,20,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL238271,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,190,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,Bioorg Med Chem Lett,2007
CHEMBL392878,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)n2)cc1N,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL418455,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL81880,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL245688,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL245479,CN(C)c1ccc(/C=C/c2cc(I)cc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL245478,CN(C)c1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL245477,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)cc3)c2)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL245476,COc1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(OC)c(OC)c3)c2)cc1OC,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL396917,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,1800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248339,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N4CCCC4)c(OC)c3)c2)ccc1N1CCCC1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248338,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248337,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)c2)cc1N(C)C,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248133,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)c2)ccc1OC,1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248132,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)c2)cc1N,300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248131,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247932,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247931,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)c2)cc1OC,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247930,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247728,COc1cc(/C=C/c2cc(N(C)C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247727,COc1cc(/C=C/c2cc(C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247726,COc1cc(/C=C/c2ccc(O)c(OC)c2)nc(/C=C/c2ccc(O)c(OC)c2)c1,1700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247530,COc1cc(/C=C/c2cc(Cl)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL427878,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247328,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247929,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247927,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)n2)cc1O,900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL391205,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)n2)ccc1N(C)C,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247725,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(O)c3)n2)cc1O,900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247674,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)n2)cc1OC,500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL247524,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL427877,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)n2)ccc1O,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL394713,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)n2)cc1N(C)C,900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248327,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(NC)c3)n2)ccc1O,500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL248122,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)n2)ccc1OC,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,Bioorg Med Chem Lett,2007
CHEMBL450553,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,9690,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1-40) aggregation by thioflavin T formation assay,J Med Chem,2008
CHEMBL492216,CN(C)c1ccc(/C=C/c2cc3ccccc3o2)cc1,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL492217,COc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,810,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL491203,CN(C)c1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL509088,Cc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,130,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL489978,CN(C)c1ccc(/C=C/c2cc3cc(F)ccc3o2)cc1,1980,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL446870,CN(C)c1ccc(/C=C/c2cc3cc(Cl)ccc3o2)cc1,200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL489979,CN(C)c1ccc(/C=C/c2cc3cc(Br)ccc3o2)cc1,470,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL524114,CN(C)c1ccc(/C=C/c2cc3cc(I)ccc3o2)cc1,170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL524141,COc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,70,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL443097,CN(C)c1ccc(/C=C/c2cc3ccc(O)cc3o2)cc1,3620,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL491406,Cc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,3440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL491407,CN(C)c1ccc(/C=C/c2cc3ccc(F)cc3o2)cc1,2190,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL490798,CN(C)c1ccc(/C=C/c2cc3ccc(Cl)cc3o2)cc1,3210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL490799,CN(C)c1ccc(/C=C/c2cc3ccc(Br)cc3o2)cc1,1340,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL492023,CN(C)c1ccc(/C=C/c2cc3ccc(I)cc3o2)cc1,2800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL492024,COc1ccc2oc(/C=C/c3ccc(N)cc3)cc2c1,820,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL523824,CNc1ccc(/C=C/c2cc3cc(OC)ccc3o2)cc1,80,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL444393,Cl.Nc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,2950,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL490808,CNc1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1.Cl,2160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL490806,COc1ccc2cc(/C=C/c3ccc(N)cc3)oc2c1,5440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL489994,CNc1ccc(/C=C/c2cc3ccc(OC)cc3o2)cc1,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL489792,COc1ccc2oc(/C=C/c3ccc(N(C)C)c(OC)c3)cc2c1,160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL521929,COc1ccc2cc(/C=C/c3ccc(N(C)C)c(OC)c3)oc2c1,530,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL418455,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 fibril formation by thioflavin T formation,Bioorg Med Chem Lett,2008
CHEMBL515387,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1,30000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of APP in human leukocytes,Bioorg Med Chem Lett,2009
CHEMBL1788111,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],27,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1788121,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],58,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744459,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],58,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744460,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],19,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1082545,COc1ccc2nc(-c3ccc(N(C)C)nc3)sc2c1,81,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1082546,CNc1ccc(-c2nc3cc(O)ccc3s2)cn1,74,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1088617,CN(C)c1ncc(-c2nc3ccc(O)cc3s2)cn1,41,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1077196,CNc1ncc(-c2nc3ccc(O)cc3s2)cn1,267,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1087548,CNc1ccc(-c2nc3ccc(C(N)=O)cc3s2)cn1,85,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1077208,CNc1ccc2nc(-c3ccc(C(N)=O)nc3)sc2c1,35,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744461,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],182,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744462,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],204,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1082889,CNc1ccc(-c2nc3ccc(OC)cc3o2)cn1,185,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744463,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],85,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1083207,CN(C)c1ccc(-c2nc3cc(O)ccc3o2)cn1,137,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1744464,[3H]C([3H])([3H])N(c1ncc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],75,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1084943,CNc1ccc(-c2cc3ccc(O)cc3o2)cn1,45,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1084944,CNc1ccc(-c2cc3ccc(OC)cc3o2)cn1,66,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1084945,COc1ccc2cc(-c3ccc(C(N)=O)nc3)oc2c1,60,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL1084946,COc1ccc2cc(-c3ccc(C(N)=O)cn3)oc2c1,33,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,Bioorg Med Chem Lett,2010
CHEMBL93124,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,19,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL570378,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,22,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048299,Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,158,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048300,COc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,35,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048301,Oc1ccc2nc(-c3ccc(NCCCF)nc3)oc2c1,395,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048302,Oc1ccc2nc(-c3ccc(NCCF)nc3)sc2c1,33,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048303,Oc1ccc2nc(-c3ccc(NCCCF)nc3)sc2c1,66,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL579205,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,24,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048304,CNc1ccc(-c2nc3ccc(O)cc3s2)nc1F,44,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048305,CNc1ccc(-c2nc3ccc(OC)cc3s2)c(F)n1,14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048306,CNc1ccc(-c2nc3ccc(O)cc3s2)c(F)n1,124,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048307,CNc1ncc(-c2nc3ccc(O)cc3s2)cc1F,98,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048308,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,24,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048309,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)c(F)n1,19,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048310,CNc1ncc(-c2cc3cc(O)ccc3o2)cc1F,30,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048311,COc1ccc2oc(-c3ccc(C(N)=O)nc3F)cc2c1,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048312,NC(=O)c1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,44,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048313,CNc1ccc(-c2cc3cc(O)ccc3o2)nc1F,35,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2048314,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)nc1F,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),Bioorg Med Chem Lett,2012
CHEMBL2059203,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,3200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059204,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,2100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059205,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,3700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059206,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,3400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059212,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059218,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059388,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059391,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2059393,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,3300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,Bioorg Med Chem,2012
CHEMBL2063873,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,J Med Chem,2012
CHEMBL2063873,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,62000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,J Med Chem,2012
CHEMBL2063874,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,30000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,J Med Chem,2012
CHEMBL2063874,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,23000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,J Med Chem,2012
CHEMBL465398,O=C(O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](O)C1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,32800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL27246,O=C(O)/C=C/c1ccccc1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL284616,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,92900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL416955,COC(=O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL249447,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,16400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL249448,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,4700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL177126,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL2146607,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,2200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL499997,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL2146608,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2012
CHEMBL2179241,Nc1c(S(=O)(=O)c2ccc(Cl)cc2)cnc2cc(-c3ccccc3)nn12,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,J Med Chem,2012
CHEMBL2179242,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,J Med Chem,2012
CHEMBL2179243,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,J Med Chem,2012
CHEMBL1458517,Cc1nc2sc3c(c2c(=O)o1)CCCC3,1200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,J Med Chem,2012
CHEMBL2203392,Cn1cnc2cc(-c3nc4ccc(F)nc4o3)ccc21,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203391,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ncc21,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203390,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)ccc21,48.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203389,Fc1ccc2nc(-c3ccc4cc[nH]c4c3)oc2n1,45.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203388,Fc1ccc2nc(-c3ccc4ncsc4c3)oc2n1,35.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203387,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)cnc21,30.2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203386,CN1CCc2cc(-c3nc4ccc(F)nc4o3)cnc21,47,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203385,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,10.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203384,Fc1ccc2nc(-c3cnc4[nH]ccc4c3)oc2n1,25.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203383,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203382,Fc1ccc2nc(-c3ccc4[nH]ccc4c3)oc2n1,13.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203381,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cn1,41.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203380,CNc1ccc(-c2nc3ccc(F)nc3o2)cn1,102,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203379,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203378,CNc1ccc(-c2nc3ccc(F)nc3o2)cc1,23.1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2203288,COc1ccc(-c2nc3ccc(F)nc3o2)cc1,32.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Binding affinity to human amyloid beta plaque,ACS Med Chem Lett,2011
CHEMBL2337291,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,Bioorg Med Chem Lett,2013
CHEMBL2337290,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,Bioorg Med Chem Lett,2013
CHEMBL2337293,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,3700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,Bioorg Med Chem Lett,2013
CHEMBL2381403,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,6500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,Bioorg Med Chem Lett,2013
CHEMBL2381384,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,4000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,Bioorg Med Chem Lett,2013
CHEMBL2381385,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,Bioorg Med Chem Lett,2013
CHEMBL2381402,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,14000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL2381403,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,21000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL2381402,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,29000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,Bioorg Med Chem Lett,2013
CHEMBL2381384,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL2381385,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,29000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL2381386,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,36000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL2381401,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,36000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,Bioorg Med Chem Lett,2013
CHEMBL247932,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta fibril aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL723,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,30000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation after 18 hrs by DELFIA,J Med Chem,2013
CHEMBL2386874,CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2386881,CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]4C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL497,Oc1c(I)cc(Cl)c2cccnc12,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL468154,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL149082,NCCCS(=O)(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,12350,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402063,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,18350,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402075,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,10320,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402074,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,13070,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402067,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,7560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402161,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,14160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402160,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,6510,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402159,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,7060,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402158,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,7870,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402157,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,10220,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402163,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,10660,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL2402162,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,12200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,J Med Chem,2013
CHEMBL129795,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,19700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408097,COc1ccc(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(O)c1,18500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408096,COC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,23800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408095,COc1ccc(C(=O)/C=C/c2cc(Br)c(OCc3ccccc3)c(OC)c2)c(O)c1,12500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL260867,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,9700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL258752,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(O)c1,10200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408094,CCOCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL229907,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408093,COc1ccc(C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)c(O)c1,7800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408092,CCOCCOc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,10500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408091,COc1ccc(C(=O)/C=C/c2ccc(OCCCOc3ccccc3)c(OC)c2)c(O)c1,10900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2407101,CCOCCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1OC,5800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408265,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3cc([N+](=O)[O-])ccc3O)cc2)c(O)c1,13300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408264,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3O)cc2)c(O)c1,10100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408263,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3OC)cc2)c(O)c1,7300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408262,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccc(C)cc3C)cc2)c(O)c1,8300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408261,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N(C)c3ccccc3)cc2)c(O)c1,20100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408106,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCc3ccccc3)cc2)c(O)c1,18900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408105,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCCc3ccccc3)cc2)c(O)c1,19100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408104,CCCCCCCCCCCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,15900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408103,CCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408102,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NC(C)C)cc2)c(O)c1,17800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408101,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,3200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408100,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCCC3)cc2)c(O)c1,5900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408099,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(C)CC3)cc2)c(O)c1,2200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL2408098,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCC3)cc2)c(O)c1,14600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,Eur J Med Chem,2013
CHEMBL573,O=C(O)c1cccnc1,13100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL858,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,28400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425961,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425960,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425959,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425958,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425957,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425956,Cc1nc2c(/C=C/C(=O)NO)cccc2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425955,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425954,Cc1nc2ccc(/C=C/C(=O)NO)cc2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL2425953,Cc1nc2cccc(/C=C/C(=O)NO)c2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,J Med Chem,2013
CHEMBL573,O=C(O)c1cccnc1,43700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL858,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,7700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425961,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,6800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425960,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,5500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425959,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,7400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425958,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,9500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425957,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,18100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425956,Cc1nc2c(/C=C/C(=O)NO)cccc2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425955,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,18400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425954,Cc1nc2ccc(/C=C/C(=O)NO)cc2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL2425953,Cc1nc2cccc(/C=C/C(=O)NO)c2c(=O)n1-c1ccccc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,J Med Chem,2013
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436692,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,11500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436691,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,12600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436690,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,4800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436710,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436704,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,9600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436703,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,6500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436702,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436701,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436700,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,17300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436699,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436698,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,9800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436697,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436696,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,12800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436695,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436694,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL2436693,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2013
CHEMBL3087683,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,6880,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087680,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4430,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087679,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4770,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087677,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,6110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087676,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087675,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,8180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3087674,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL231160,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,Bioorg Med Chem Lett,2013
CHEMBL3099500,CN(CCCCNc1c2c(nc3c(NC(=O)CNC(=O)CC[C@H](NC(=O)CNC(=O)OCc4ccccc4)C(=O)N[C@@H](Cc4ccccc4)C(=O)OCc4ccccc4)cccc13)CCCC2)CCCNc1c2c(nc3ccccc13)CCCC2,51000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by ThT-based fluorescence assay,ACS Med Chem Lett,2013
CHEMBL541265,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Destabilization of preformed amyloid beta (1 to 40) (unknown origin),Bioorg Med Chem Lett,2014
CHEMBL541265,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) aggregation (unknown origin),Bioorg Med Chem Lett,2014
CHEMBL3235503,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation,J Med Chem,2014
CHEMBL3286981,COc1cc(/C=c2\sc3nc(-c4ccncc4)cn3c2=O)cc(OC)c1O,93,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286982,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(OC)c1O,7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286983,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Cl)c1O,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286984,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Br)c1O,18,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286985,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(O)c1O,18,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286986,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)ccc1O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286987,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)cc(OC)c1O,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286988,COc1cc(/C=c2\sc3nc(-c4cccc(Cl)c4)cn3c2=O)cc(OC)c1O,6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286989,COc1cc(/C=c2\sc3nc(-c4cccc(C(F)(F)F)c4)cn3c2=O)cc(Cl)c1O,123,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL3286990,COc1cc(/C=c2\sc3nc(-c4cccc(OC(F)(F)F)c4)cn3c2=O)cc(F)c1O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,ACS Med Chem Lett,2014
CHEMBL191083,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330737,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(=O)O,410,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330738,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330739,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,7100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330740,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(N)=O,1500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330741,O=C1NC(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330742,CN1C(=O)C(=Cc2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)s3)s2)C(=O)N(C)C1=O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330743,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330744,N#CC(C#N)=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330745,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)c3nsnc23)s1)C(N)=O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330746,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=O)s3)cc21,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330747,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(C=C(C#N)C#N)s3)cc21,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330748,CC(C)(C)n1c2cc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)sc2c2sc(-c3ccc(/C=C(\C#N)C(N)=O)s3)cc21,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330749,COc1ccc(-c2ccc(-c3ccc(C=O)s3)s2)cc1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330750,COc1ccc(-c2ccc(-c3ccc(C=C(C#N)C#N)s3)s2)cc1,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330751,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=O)s4)cc2n3C(C)(C)C)cc1,380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330752,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(C=C(C#N)C#N)s4)cc2n3C(C)(C)C)cc1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330753,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(/C=C(\C#N)C(N)=O)s4)cc2n3C(C)(C)C)cc1,550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330754,O=Cc1ccc(-c2ccc(-c3ccc4[nH]ccc4c3)s2)s1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330735,CN(C)c1ccc2nc3ccc(N)cc3[s+]c2c1.[Cl-],3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3330736,CNc1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL253570,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2c(O)c(O)cc(O)c12,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,Eur J Med Chem,2014
CHEMBL3326698,O=C(NCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2oc1=O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL3326704,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2ccccc2oc1=O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL3326707,Cc1ccc2oc(=O)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL3326709,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2cc(OC(F)(F)F)ccc2oc1=O,24200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL3327246,COc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,13400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL3327247,Cc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,6100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,Bioorg Med Chem,2014
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,4600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,Bioorg Med Chem Lett,2014
CHEMBL3298066,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,Bioorg Med Chem Lett,2014
CHEMBL151,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,Bioorg Med Chem Lett,2014
CHEMBL3297746,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,Bioorg Med Chem Lett,2014
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta1-40 (unknown origin) aggregation,Bioorg Med Chem Lett,2014
CHEMBL2206986,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC(=O)N6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2206995,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C(=O)C(C)C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207065,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207043,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207042,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207069,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CNCCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,91,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2206994,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207044,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCOC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2207050,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCN6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2206992,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6(C)COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL2206993,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CNC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403815,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403817,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403818,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,130,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403819,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,68,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403820,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403822,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403823,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403824,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403825,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403826,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403827,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL3403816,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,Bioorg Med Chem Lett,2015
CHEMBL576840,O=C(Cc1ccccc1)NC(CSSCC(NC(=O)Cc1ccccc1)C(=O)O)C(=O)O,1950,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,Bioorg Med Chem,2015
CHEMBL3400292,CNc1ccc(C(=O)NC(CCCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,2750,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,Bioorg Med Chem,2015
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582126,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,95900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582127,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,28000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582128,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,34300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582129,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,71900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582130,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,10100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582132,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,1200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3582133,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,43500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL549959,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)C(=O)C[C@H]2O)CCC4=O,13400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL231160,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,Medchemcomm,2014
CHEMBL3087676,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,Medchemcomm,2014
CHEMBL3087674,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,Medchemcomm,2014
CHEMBL3593276,CCN1/C(=C/C=C/c2sc3ccc(OCCCO[N+](=O)[O-])cc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.O=S(=O)([O-])C(F)(F)F,26000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3593277,CCN1/C(=C/C=C/c2sc3ccc(OCc4no[n+]([O-])c4C(N)=O)cc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.O=S(=O)([O-])C(F)(F)F,17000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3593280,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.[I-],26000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL81782,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21.[I-],3300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3593278,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.[I-],7700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3593279,CCN1/C(=C/C=C/c2sc3ccccc3[n+]2CC)Sc2ccc(Oc3no[n+]([O-])c3-c3ccccc3)cc21.[I-],1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3593282,CCCOc1ccc2c(c1)N(CC)/C(=C/C=C/c1sc3ccccc3[n+]1CC)S2.[I-],800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation assessed as amount of fibrils formation after 2 hrs by thioflavin T based spectrofluorimetric method,Bioorg Med Chem,2015
CHEMBL3594076,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)ccc1O,4300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3594077,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1,15800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3594078,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3594079,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc(OC)c1O,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL116438,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,J Nat Prod,2015
CHEMBL3622510,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,15000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,ACS Med Chem Lett,2015
CHEMBL3621634,Oc1ccc(/C=C/c2ccc(O)c3ncccc23)cc1,8500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by ThT assay,Medchemcomm,2015
CHEMBL3622258,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,3960,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation by thioflavin-T fluorescence assay,Medchemcomm,2014
CHEMBL3740785,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,244300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3741682,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1OC=CC(C)(C)O2,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3742121,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3741529,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)N(C)C3=O)C(=O)Nc1cc2c(cc15)OC(C)(C)C=CO2,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3739748,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,269500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3741300,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,203700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3741111,CC1=CC[C@@H]2[C@@]3(C)[C@@H](O)CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3739499,CC1=CC[C@@H]2[C@@]3(C)C=CC(=O)OC(C)(C)[C@@H]3CC[C@@]2(C)[C@]12Cc1c(c(C)c(C)oc1=O)O2,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3740688,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,186600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3742151,CC(=O)O[C@H]1CC(=O)OC(C)(C)[C@@H]2CC[C@]3(C)[C@H](CC=C(C)[C@@]34C[C@]3(OC(C)=C(C)C3=O)C(=O)O4)[C@@]12C,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL469159,CC1(C)C=Cc2cc(C(=O)O)ccc2O1,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL324842,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,71900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,J Nat Prod,2015
CHEMBL3740705,COc1cccc(N2N=C(C)CC2=O)c1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3739861,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3741643,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,26000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3741680,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,27000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3741909,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,5600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3741268,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,3400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3742091,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,14500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL3741747,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,19600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,Bioorg Med Chem Lett,2016
CHEMBL290916,CC1=NN(c2ccccc2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL1880288,CC1=NN(c2ccccc2C)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3742311,CC1=NN(c2cccc(C)c2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740157,CC1=NN(c2ccc(C)cc2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3739456,CC1=NN(c2ccc3ccccc3c2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740761,CCc1ccccc1N1N=C(C)CC1=O,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740979,CC1=NN(c2cc(C)ccc2C)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741747,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,3500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3742091,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,3900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741268,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,5100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741909,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,19500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3742036,COc1cc(N2N=C(C)CC2=O)nc(OC)n1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740667,CC1=NN(c2cccnc2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741680,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741643,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,4000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740581,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,16800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3739861,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,4000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740705,COc1cccc(N2N=C(C)CC2=O)c1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3739947,COc1cc(F)cc(N2N=C(C)CC2=O)c1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3740346,CC1=NN(c2ccc(C(F)(F)F)cc2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3741408,CC1=NN(c2ccc(C)c(F)c2)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL3742186,CC1=NN(c2cc(F)ccc2C)C(=O)C1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,Bioorg Med Chem Lett,2016
CHEMBL28626,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,30300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL66,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,33000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,15300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,15100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL309490,O=c1c(O)c(-c2ccccc2)oc2cc(O)cc(O)c12,500000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL150,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL503168,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,55400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL3752685,Cl.Cl.c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T-based fluorometric assay,J Med Chem,2016
CHEMBL3751854,COc1ccc(CC(=O)Nc2nc(-c3ccccc3)cs2)cc1,10600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,Bioorg Med Chem Lett,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,Bioorg Med Chem Lett,2016
CHEMBL3781419,Cc1ccc(-c2cc(NCCNc3cc(-c4cccs4)[nH]n3)n[nH]2)cc1,29000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,Eur J Med Chem,2016
CHEMBL3781022,CN(C)c1ccc(-c2cc(NCCNc3cc(-c4ccc(N(C)C)cc4)[nH]n3)n[nH]2)cc1,7500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,Eur J Med Chem,2016
CHEMBL3781026,Fc1ccc(-c2cc(NCCNc3cc(-c4ccc(F)cc4)[nH]n3)n[nH]2)cc1,40500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,Eur J Med Chem,2016
CHEMBL3797646,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1,71.28,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3797706,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,22.54,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3799558,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,51.81,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3798857,O=C(COC(=O)Cc1ccc(O)cc1)Nc1c2c(nc3ccccc13)CCCC2,45.29,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3797623,O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,77.45,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3798989,COc1cc(OC)cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c1,55.86,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3797363,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,30.74,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3799703,COc1ccc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,65.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3797381,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)ccc1O,37.36,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3800453,O=C(COC(=O)c1ccc(O)c(O)c1)Nc1c2c(nc3ccccc13)CCCC2,17.36,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3800317,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,49.14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3799950,COc1cc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,45.88,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3798813,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1O,46.12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3799175,O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,51.77,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3799641,O=C(COC(=O)Cc1c[nH]c2ccccc12)Nc1c2c(nc3ccccc13)CCCC2,38.96,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL95,Nc1c2c(nc3ccccc13)CCCC2,12.21,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,4100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814397,Nc1nc(NCC2CCCCC2)nc2ccccc12,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815140,CC(C)Nc1nc(N)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814981,CCCNc1nc(N)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814610,Nc1nc(NCCc2ccccc2)nc2ccccc12,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814189,Nc1nc(NCc2ccc(F)cc2)nc2ccccc12,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813837,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,14700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814001,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814125,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815148,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,8100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814191,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,13400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814611,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,5300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815150,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,13800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814909,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814324,COc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813859,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,22500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814103,Cc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814134,Nc1nc(NCc2ccccc2)nc2ccccc12,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL410263,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],8700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815002,Nc1nc(NCC2CCCCC2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814123,Nc1nc(NCCc2ccccc2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3357256,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814748,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814631,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,14800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814270,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,22300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813811,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814383,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814660,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814349,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,21000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813788,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813971,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814363,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815078,Nc1nc(NCc2ccccc2)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,2600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814397,Nc1nc(NCC2CCCCC2)nc2ccccc12,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815140,CC(C)Nc1nc(N)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814981,CCCNc1nc(N)c2ccccc2n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814610,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814189,Nc1nc(NCc2ccc(F)cc2)nc2ccccc12,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813837,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,11300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814001,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814125,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,1500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815148,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814191,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,5900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814611,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815150,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,12500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814909,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,6800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814324,COc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813859,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,13100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814103,Cc1cccc(CNc2nc(N)c3ccccc3n2)c1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814134,Nc1nc(NCc2ccccc2)nc2ccccc12,2200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL410263,O=S(=O)([O-])c1cc(S(=O)(=O)[O-])c2c(/N=N/c3ccccc3)c(O)ccc2c1.[Na+].[Na+],3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815002,Nc1nc(NCC2CCCCC2)c2ccccc2n1,13600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814965,CC(C)Nc1nc(N)nc2ccccc12,10200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814813,CCCNc1nc(N)nc2ccccc12,14900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814123,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3357256,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,3100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814748,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,2800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814631,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,80,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814270,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,580,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813811,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,620,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814383,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814660,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814349,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,3500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813788,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814429,COc1cccc(CNc2nc(N)nc3ccccc23)c1,20600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3813971,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,3900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3814363,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,3600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL3815078,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,ACS Med Chem Lett,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL429694,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3815004,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,35000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3814529,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,17000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3814719,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3814159,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3813916,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,240000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3814563,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,280000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3818600,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,9200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL3819454,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,11750,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL3818053,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,10110,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,Bioorg Med Chem,2016
CHEMBL3942680,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)cc1OC,4600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL405110,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1.[Cl-],500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3953399,COc1cc(OCc2ccccn2)ccc1/C=C/c1cc(/C=C/c2ccc3cc[nH]c3c2)[nH]n1,1200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3948937,COc1cc(OCc2ccccn2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,470,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3901022,COc1cc(OCc2ccccc2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3938007,COc1cc(OCC2CCCO2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,2500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3965306,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)c(OC)c1,610,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3911126,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3981143,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccco2)ccc1O,760,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3889997,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccnc2)ccc1O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3892054,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccccc2)ccc1O,2200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3950384,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,420,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3922663,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3ccccc3c2)ccc1O,590,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3978488,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,3700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3672436,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c(O)c1,930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3970179,COc1cc(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3940632,COc1ccc(O)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3672401,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2OC)ccc1O,920,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3969106,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2OC)ccc1O,1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3672439,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2c(O)cccc2OC)ccc1O,1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3958051,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1O,2100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3911667,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(O)c2OC)ccc1O,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3986412,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(OC)c2O)ccc1O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem Lett,2016
CHEMBL3922564,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,9470,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18250,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,Eur J Med Chem,2016
CHEMBL3883958,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,66360,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation incubated for 48 hrs under dark condition by ThT fluorescence assay,Bioorg Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,630,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by ThT fluorescence assay,Bioorg Med Chem,2017
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,7940,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin),Bioorg Med Chem,2017
CHEMBL3944195,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,12200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2017
CHEMBL3925265,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,7400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2017
CHEMBL3913721,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,10900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2017
CHEMBL3951861,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,9900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2017
CHEMBL1086286,CCS(=O)(=O)NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222066,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL1086287,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222067,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL3659993,CC(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222068,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL3659994,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCO[C@@H](CCC(O)CO)[C@@H]1COc1c(F)ccc(F)c12,15,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222069,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL1090210,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C1CC1,8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222070,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL3659995,O=C(C[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)NCC(F)(F)F,25,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222071,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL3659992,CCS(=O)(=O)CC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,10,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222072,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL1090209,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C(F)(F)F,27,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222073,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL1778349,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@]2(O)C1)C1CC1,29,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222074,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL1085076,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,54,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,222075,"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",,2013
CHEMBL3667019,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)CC(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282629,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667020,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282630,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667021,CC(C)(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,15000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282631,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667022,COC(=O)CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282632,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667023,COC(=O)CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282633,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667024,CCOC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282634,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667025,CC(C)(C)OC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,650,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282635,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667026,O=C(O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282636,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667027,CCOC(=O)C(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282637,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667028,COC(=O)CCC(C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc([O-])c(OC(F)(F)F)c1.[Na+].[Na+],560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282638,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667029,COCOCCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282639,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667030,CN(C)C(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282640,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667031,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(CCOCCO)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282641,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667032,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282642,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667033,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OCC(=O)O)c(OC)c2)ccc1O,310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282643,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3639383,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(C(F)(F)F)c2)ccc1O,130,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282644,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667034,CNc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(NC)c(C(F)(F)F)c2)cc1C(F)(F)F,5800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282645,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667035,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cncc(C(F)(F)F)c2)ccc1O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282646,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667036,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1,360,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282647,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667037,N#CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282648,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667038,CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,320,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282649,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL3667039,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccco1,650,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,282650,"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",,2015
CHEMBL4112651,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@]21N=C(C)C(N)=N1,2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297411,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3893021,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@@]21N=C(C)C(N)=N1,1.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297412,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3959097,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,56,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297413,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3898248,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1[C@@]21N=C(C)C(N)=N1,0.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297414,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672698,CC1=N[C@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,1.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297415,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672702,CC[C@@H](C)Oc1ccc2c(c1)C1(N=C(C)C(N)=N1)[C@]1(CC[C@H](OC)CC1)C2,16,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297416,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672687,CC1=NC2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,2.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297417,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672688,CC1=N[C@@]2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,96,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297418,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3891777,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,2.1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297419,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3945110,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1C21N=C(C)C(N)=N1,678,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297420,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL4110988,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@]21N=C(C)C(N)=N1,0.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297421,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3959097,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,0.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297422,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672695,CC1=N[C@]2(N=C1N)c1cc(OCCCF)ccc1C[C@]21CC[C@@H](OC(F)F)CC1,1.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297423,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3899321,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC(C)F)cc1C21N=C(C)C(N)=N1,2.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297424,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672699,CC1=N[C@@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,216,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297425,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3653726,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](O)CC2)C3)c1,1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297426,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3937729,[C-]#[N+]c1cc(Cl)cc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297439,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3947671,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,1.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297440,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL4113193,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@]21N=C(C)C(N)=N1,986,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297441,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3943188,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,4.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297442,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3913223,CC#Cc1cncc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297443,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672708,COC1CCC2(CC1)Cc1cc(F)c(Br)cc1C21N=C(C)C(N)=N1,176,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297444,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3902640,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,0.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297445,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3969309,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cncc(Cl)c3)cc1C21N=C(C)C(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297446,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3916194,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,7.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297447,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672718,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(C#N)c3)ccc1CCC21CC1,23,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297465,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672719,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(F)c3)ccc1CCC21CC1,118,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297466,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672720,CC1=NC2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1CCC21CC1,11,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297467,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672721,CO[C@H]1CC[C@@]2(CCc3ccc(Br)cc3C23N=C(C)C(N)=N3)CC1,78,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297468,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672723,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297469,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672724,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,80,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297470,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672725,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,2.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297471,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672726,CO[C@H]1CC[C@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,19,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297472,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672727,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,81,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297473,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672728,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,2.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297474,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672729,CC1=NC2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1CCC21CC1,16,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297475,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672730,COC1CCC2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,3.1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297476,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672731,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,92,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297477,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3672732,CO[C@H]1CC[C@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,4.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297478,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3915935,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3(C)CC3)cc1C21N=C(C)C(N)=N1,2.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297489,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3891403,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC(F)(F)C3)cc1C21N=C(C)C(N)=N1,8.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297490,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3923244,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1C21N=C(C)C(N)=N1,1.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297491,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3937398,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1[C@@]21N=C(C)C(N)=N1,0.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297492,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3905816,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3(F)F)cc1C21N=C(C)C(N)=N1,2.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297493,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3961886,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1C21N=C(C)C(N)=N1,1.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297494,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3927449,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,1.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297495,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3939963,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC3CC3)cc1C21N=C(C)C(N)=N1,0.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,297496,"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",,2015
CHEMBL3692695,O=C(Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1)c1ccc(C(F)(F)F)cc1,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305517,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692696,O=C(Cc1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305518,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692697,O=C(CCc1cc(C(F)(F)F)ccc1C(F)(F)F)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,630000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305519,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692698,O=C(CCOc1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305520,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692699,O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,84000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305521,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692700,O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,200000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305522,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL3692701,CN1C(=O)[C@@H](NCC(=O)Nc2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)c2ccc(Cl)s2)N=C(c2ccccc2)c2ccccc21,800000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,305523,"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",,2015
CHEMBL4111029,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,840,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,306770,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4114267,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)OCC2(F)F)n1,7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335587,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386720,C[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)OCC1(F)F,8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335588,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386721,CC1(C)OC(N)=N[C@](C)(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C1(F)F,7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335589,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386722,COCC[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,49,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335590,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL3902027,COCC[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335591,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4108431,COCC[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335592,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386723,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,27,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335593,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4110279,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335594,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386724,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)OCC1(F)F,12,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335595,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4108635,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335596,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386725,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335597,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4114995,C[C@]1(c2nc(NC(=O)c3ncc(OCCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335598,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4111654,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(C)c1,82,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335599,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4110143,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)c1,540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335600,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4110172,C[C@]1(c2nc(NC(=O)c3ncc(OCF)nc3N)ccc2F)N=C(N)OCC1(F)F,30,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335601,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4107314,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3N)ccc2F)N=C(N)OCC1(F)F,62,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335602,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4109969,C[C@]1(c2nc(NC(=O)c3ncc(F)cc3N)ccc2F)N=C(N)OCC1(F)F,88,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335603,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4115329,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3N)ccc2F)N=C(N)OCC1(F)F,45,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335604,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4106556,C[C@]1(c2nc(NC(=O)c3ncccc3Cl)ccc2F)N=C(N)OCC1(F)F,88,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335605,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4107875,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,81,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335606,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4112705,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,60,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335607,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4114553,C[C@]1(c2nc(NC(=O)c3ncc(OCCCl)nc3N)ccc2F)N=C(N)OCC1(F)F,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335608,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4115141,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,250,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335609,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4108335,C[C@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,480,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335610,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4111699,C[C@]1(c2nc(NC(=O)c3ncc(OCF)cc3Cl)ccc2F)N=C(N)OCC1(F)F,57,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335611,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4109860,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,450,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335612,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4110497,COCCc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,70,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335613,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386726,C[C@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,13,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335614,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4110655,C[C@]1(c2nc(NC(=O)c3nccnc3N)ccc2F)N=C(N)OCC1(F)F,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335615,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4113786,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3Cl)ccc2F)N=C(N)OCC1(F)F,19,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335616,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4112589,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)cc3N)ccc2F)N=C(N)OCC1(F)F,66,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335617,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4108644,CC(F)(F)c1nc(N)c(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)nc1Cl,6500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335618,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL2386719,C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)OCC1(F)F,14,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335619,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4111183,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,58,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335620,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL4111103,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,335621,"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",,2015
CHEMBL3943313,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)CCn1cccn1,1.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356362,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3934479,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ccccn1,1.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356363,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3961972,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1cccnc1,6.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356364,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3956918,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ncon1,1.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356365,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3957316,Cc1nc(CS(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)no1,5.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356366,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3971184,O=c1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)c[nH]1,18.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356367,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3948649,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cccnn1,4.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356368,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3904071,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cnccn1,5.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356369,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3935559,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccnnc1,10.2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356370,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3928118,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ncccn1,6.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356371,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3900140,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccncn1,2.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356372,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3909054,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cncnc1,12.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356373,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3905561,COc1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)cn1,16.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356374,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3941787,O=c1[nH]cccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,2.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356375,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3984227,Nc1ncccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,18,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,356376,"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629737,CC1(C)OCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,66.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436730,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629739,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(COC3)[C@@H]1COc1c(F)ccc(F)c12,10.1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436731,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629738,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCC[C@]3(CCOC3)[C@@H]1COc1c(F)ccc(F)c12,13.9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436732,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629740,O=C1OCC[C@]12CCC[C@@]1(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]21,228,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436733,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629742,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(CCSCC3)[C@@H]1COc1c(F)ccc(F)c12,26.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436734,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629741,O=S1(=O)CCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CC1,57.7,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436735,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629743,O=S(=O)(N1CC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)C1)C(F)(F)F,23.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436736,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3899794,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,9.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436737,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3936795,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,421,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436738,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3905228,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,397,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436739,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3942223,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,79,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436740,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL3629745,CP1(=O)OCC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,5.4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,436741,"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",,2016
CHEMBL4059796,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,18970,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4077009,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,19440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4092433,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,29220,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4074429,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,23390,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4097746,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,8940,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4070599,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,16500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4086825,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,12480,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4074006,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,10720,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4068105,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,15380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4095488,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,21760,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,Eur J Med Chem,2017
CHEMBL4069995,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,23800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4072261,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,17800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4066527,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,26600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4104210,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,25600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4096474,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,15300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4088780,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,24000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4098927,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,30000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4104620,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,24000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4063009,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,48000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4084675,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL4101130,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,42000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL429694,Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)[O-])c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)[O-])c2ccccc12.[Na+].[Na+],1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2017
CHEMBL118193,Clc1nc(NCc2ccccc2)c2ccccc2n1,16700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4087140,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,8200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4065718,Clc1nc(NCCc2ccccc2)c2ccccc2n1,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4070983,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4092601,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,12000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL117804,c1ccc(CCNc2ncnc3ccccc23)cc1,11900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4089722,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,7200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4079415,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,2600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4097449,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3815078,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4071318,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,2700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3814123,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4081859,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,7800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4082825,Oc1nc(NCc2ccccc2)c2ccccc2n1,270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4100806,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,10400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4096595,Oc1nc(NCCc2ccccc2)c2ccccc2n1,11200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3814134,Nc1nc(NCc2ccccc2)nc2ccccc12,2200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3814610,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4060687,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,8300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4081013,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,13300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4099046,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,14400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4070380,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4091317,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,3100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4061746,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4083524,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,1700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4097374,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,8300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4079345,CCNc1nc(NCc2ccccc2)c2ccccc2n1,7000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4105088,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3262251,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,4400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4067481,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,5700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4094911,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,6600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4078382,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4102655,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,4300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4086248,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4064773,CNc1nc(NCCc2ccccc2)c2ccccc2n1,2000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4061837,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,1400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4083601,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,4400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4070462,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,3800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4091385,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,790,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL4087140,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL3814134,Nc1nc(NCc2ccccc2)nc2ccccc12,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40 residues) (unknown origin) fibril formation by thioflavin-T fluorescence based assay,J Med Chem,2017
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,124600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,14800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL3348861,O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O,12800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL150,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL9323,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)cc2)[C@H]1O,500000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,176200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 1 hr by thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) aggregation after 46 to 48 hrs by Thioflavin T fluorescence assay,J Nat Prod,2017
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,23000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of recombinant amyloid beta (1 to 42) fibrils (unknown origin) by thioflavin-T fluorescence assay,J Nat Prod,2017
CHEMBL241190,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,5700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4127947,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4126558,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,22700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4126715,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,87800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4129983,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4125745,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccc(O)cc1)C(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL2392127,O=C(/C=C/c1ccc(O)c(O)c1)N[C@@H](Cc1ccccc1)C(=O)O,72900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4129190,O=C(/C=C/c1ccc(O)cc1)N[C@@H](Cc1ccccc1)C(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL3276007,O=C(/C=C/c1ccccc1)N[C@@H](Cc1ccccc1)C(=O)O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL2296789,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL115421,O=C(/C=C/c1ccc(O)c(O)c1)N[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4126073,COC(=O)[C@H](Cc1ccc(OC)c(OC)c1)NC(=O)/C=C/c1ccc(OC)c(OC)c1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4127090,O=C(CCc1ccc(O)c(O)c1)N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,8700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,Bioorg Med Chem,2018
CHEMBL181529,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,138,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Displacement of [125I]IMPY from fibrillar amyloid beta 42 (unknown origin) after 3 hrs,Bioorg Med Chem Lett,2018
CHEMBL4166095,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,9000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,Eur J Med Chem,2017
CHEMBL32749,COc1cc(/C=C/C(=O)O)ccc1O,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,Eur J Med Chem,2017
CHEMBL98521,O=C(O)/C=C/c1cccc(O)c1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,Eur J Med Chem,2017
CHEMBL32823,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,Eur J Med Chem,2017
CHEMBL4175715,C=CCOC(=S)/C=C/c1ccc(O)c(O)c1,12500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,Eur J Med Chem,2017
CHEMBL4176742,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,10430,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4172159,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,11550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4161552,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,15890,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4168812,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,13400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4173299,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,16290,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4161947,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,18310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4169871,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,25000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4167322,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,23540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4175196,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,17850,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4170265,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,18550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4162346,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,20720,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4166865,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,17600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4163412,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,18050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4174114,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,23800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,22510,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,Eur J Med Chem,2017
CHEMBL4176559,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,5840,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL4161849,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,8280,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL1171146,C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,14990,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL4217978,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,43600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,Eur J Med Chem,2018
CHEMBL4207221,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,85500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,Eur J Med Chem,2018
CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,7000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL682,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,4000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL138623,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,4500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL317760,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL451753,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL94521,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,3100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4227472,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,2500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL97247,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL319756,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL167970,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,5100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226945,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226951,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226684,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCOCC2)cc(C(=O)NCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4225384,CN1CCN(Cc2ccccc2Nc2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4225842,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,8200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226025,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,4600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4225563,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,6600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226959,CN1CCN(Cc2ccccc2Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226332,CN(C)Cc1ccccc1Nc1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4228998,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,6200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226906,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCOCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226598,CN1CCN(Cc2ccccc2-c2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226641,CN(C)Cc1ccccc1-c1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4227708,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4227244,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4226530,CN1CCN(Cc2ccccc2-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL4227963,CN(C)Cc1ccccc1-c1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,Bioorg Med Chem,2018
CHEMBL76,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,12800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL682,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL138623,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,10400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL317760,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL451753,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,13800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL94521,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,7100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4227472,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL97247,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL319756,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL167970,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,11200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226945,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226951,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226684,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCOCC2)cc(C(=O)NCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4225384,CN1CCN(Cc2ccccc2Nc2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4225842,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226025,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,6000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4225563,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,7900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226959,CN1CCN(Cc2ccccc2Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226332,CN(C)Cc1ccccc1Nc1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4228998,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,9400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226906,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCOCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226598,CN1CCN(Cc2ccccc2-c2cc(C(=O)NCCN3CCCCC3)cc(C(=O)NCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226641,CN(C)Cc1ccccc1-c1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4227708,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4227244,c1ccc(-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4226530,CN1CCN(Cc2ccccc2-c2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)CC1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL4227963,CN(C)Cc1ccccc1-c1cc(CNCCN2CCCCC2)cc(CNCCN2CCCCC2)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,Bioorg Med Chem,2018
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,12430,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4228823,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,8860,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4226059,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,18940,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4227890,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,11440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4227615,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4226505,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,16810,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4227357,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,7350,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4228027,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,17330,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4225226,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,22550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4225986,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,19740,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4226827,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5640,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4226831,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,18280,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4225989,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,20610,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Bioorg Med Chem,2018
CHEMBL194823,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,45000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta amyloid (unknown origin) deposition,Eur J Med Chem,2018
CHEMBL4282190,O=c1cc(/C=C/c2cccc(F)c2)occ1O,17680,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4294375,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,5920,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4286002,COc1ccccc1/C=C/c1cc(=O)c(O)co1,7930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4287929,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4284208,O=c1cc(/C=C/c2ccccc2O)occ1O,8290,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL4294830,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,17950,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,Bioorg Med Chem,2018
CHEMBL197478,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Eur J Med Chem,2018
CHEMBL145,O=C(O)/C=C/c1ccc(O)c(O)c1,15600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Eur J Med Chem,2018
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Eur J Med Chem,2018
CHEMBL197478,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,Eur J Med Chem,2018
CHEMBL289556,O=C(N[C@H]1CCS[C@H]2CCC[C@@H](C(=O)O)N2C1=O)[C@@H](S)Cc1ccccc1,199.53,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of APP (unknown origin),ACS Med Chem Lett,2019
CHEMBL4435800,CCOc1nc(CC)c(CNC(=O)[C@@H](S)CC(C)C)n1Cc1ccc(-c2ccccc2C(=O)O)cc1F,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of APP (unknown origin),ACS Med Chem Lett,2019
CHEMBL4462662,CCN(CC)CCCOc1ccc(-n2ccc(=O)c(O)c2C)cc1,17230,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) incubated for 24 hrs by TEM analysis,J Med Chem,2019
CHEMBL4465480,CCN(CC)CCCCC(C)Nc1c2ccccc2nc2c(C(=O)NCCCO/N=C/C(=O)NCCCC[C@@H]3NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C3=O)cccc12,2000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation,Medchemcomm,2018
CHEMBL3235503,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation by thioflavin T based fluorescence assay,Bioorg Med Chem,2019
CHEMBL4438040,Cl.O=c1c2c(F)cccc2[se]n1-c1cc(Cl)c(O)c2ncccc12,9600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation,Eur J Med Chem,2019
CHEMBL4475538,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,60,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells incubated for 48 hrs by fluorescence microscopy,Eur J Med Chem,2019
CHEMBL4522050,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,8065,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2019
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,6385,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2019
CHEMBL4568384,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,46420,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Medchemcomm,2018
CHEMBL4439214,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,44520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,Medchemcomm,2018
CHEMBL4588767,OB1Oc2ccc3ccccc3c2C=C1c1cc(O)cc(O)c1,12600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4552863,OB1Oc2ccc3cc(O)ccc3c2C=C1c1cc(O)cc(O)c1,8900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4455417,OB1Oc2ccc3ccc(O)cc3c2C=C1c1cc(O)cc(O)c1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4476718,OB1Oc2ccc3cc(O)ccc3c2C=C1c1ccc(O)c(O)c1,4600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4444573,OB1Oc2ccc3ccc(O)cc3c2C=C1c1ccc(O)c(O)c1,3400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4466197,OB1Oc2cc(O)ccc2C=C1c1cc(O)cc(O)c1,21700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4468824,OB1Oc2ccc(O)cc2C=C1c1ccc(O)c(O)c1,17500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,16800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,13700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,Medchemcomm,2018
CHEMBL4524631,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3980,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4516540,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,4200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4439936,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,3630,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4562198,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,2410,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4440350,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4527242,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,3860,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4474151,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,3450,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4553651,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4554367,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,3710,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4463164,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,3160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4467746,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,5470,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4552250,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,2370,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4520323,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,2800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4475678,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,2310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4451935,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL231160,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2018
CHEMBL4589690,COc1ccc(-c2cc(=O)c3c(O)c(Oc4ccc(-c5cc(=O)c6c(O)cc(O)cc6o5)cc4)c(O)cc3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL3589108,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1Oc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL291426,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,9500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL3589106,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(OC)cc6)oc45)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4513568,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3o2)cc1,45600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4463033,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,17300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4536141,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4554693,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,15900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4545404,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,32800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4449738,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL3589107,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,21300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL451902,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL378516,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL453479,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL1208904,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4O)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL208908,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(OC)cc6o5)ccc4OC)c3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL208578,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL374055,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,20100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL1208903,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,10100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL208988,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL377324,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,13200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL220745,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL450522,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL378188,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,4700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL255493,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,4900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL63354,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,4800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4522982,COc1ccc(-c2cc(=O)c3c(O)c(Oc4ccc(-c5cc(=O)c6c(O)cc(O)cc6o5)cc4)c(OC)cc3o2)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL28,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,4100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2019
CHEMBL4436866,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,17440,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,Bioorg Med Chem,2019
CHEMBL4444043,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,3870,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,Bioorg Med Chem,2019
CHEMBL4444093,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,17890,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2019
CHEMBL4453548,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,15720,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,Eur J Med Chem,2019
CHEMBL6246,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,300000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta amyloid in human SH-SY5Y cells,Eur J Med Chem,2019
CHEMBL6246,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of beta amyloid (unknown origin) after 12 to 24 hrs,Eur J Med Chem,2019
CHEMBL4645437,CC(C)=CCC/C(C)=C/CCC1(C)C=Cc2c(O)cc(C)cc2O1,68000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4640668,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)c(O)c1O,16700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL1171643,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc(C)c(C(=O)O)c2O)O1,24700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL2012313,CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,62700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4643713,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c1O,221000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,7400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4646459,COc1c(O)c(O)cc(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,29300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4644047,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,150800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4638539,COc1c(O)c(O)c(-c2c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c2O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,12300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL487804,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL513978,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4641877,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)cc1O,19900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,Bioorg Med Chem Lett,2020
CHEMBL4776150,Oc1cc(CN(Cc2ccccn2)Cc2ccccn2)cc(C[P+](c2ccccc2)(c2ccccc2)c2ccccc2)c1.[Br-],12530,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 42) (unknown origin) assessed as reduction in fibril formation incubated for 24 hrs by Thioflavin T based fluorometric assay,Eur J Med Chem,2019
CHEMBL4762873,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL98,O=C(CCCCCCC(=O)Nc1ccccc1)NO,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4757035,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(F)cc23)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4796066,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4751082,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,3500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4761847,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4753795,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4750838,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,34900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4799871,O=C(NO)c1ccc(Nc2c3c(nc4ccccc24)CCCC3)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL4752558,O=C(NO)c1ccc(Nc2ccnc3ccccc23)cc1,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL28626,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,8500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,Eur J Med Chem,2020
CHEMBL81379,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,Eur J Med Chem,2019
CHEMBL986,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,Eur J Med Chem,2019
CHEMBL4787961,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)CCCC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,Eur J Med Chem,2019
CHEMBL38,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,Eur J Med Chem,2019
CHEMBL4755968,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,19710,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL4791642,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,2050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL4750451,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,15120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL4763981,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,18300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,13430,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,16250,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2020
CHEMBL4755924,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,7050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,J Med Chem,2020
CHEMBL4744947,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,5060,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,J Med Chem,2020
CHEMBL4740154,C#CCN(C)CCCn1ccc(=O)c(O)c1C,2850,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThT fluorescence assay,J Med Chem,2020
CHEMBL4874567,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2[nH]1,2160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4861956,COc1ccc2[nH]c(C(=O)Nc3ccc4nc5n(c(=O)c4c3)CCC5)cc2c1,1210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4854341,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(F)ccc2[nH]1,1560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4871461,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(Cl)ccc2[nH]1,1690,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4864253,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2o1,3260,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4871713,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2s1,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4878452,O=C(Cc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,1620,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4853181,O=C(/C=C/c1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,3090,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4870177,O=C(CCCc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,5270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4861631,COc1ccc2[nH]c(C(=O)Nc3cc4c(=O)n5c(nc4cc3C)CCC5)cc2c1,6100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4856921,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(F)ccc2[nH]1)CCC3,3270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL4854859,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(Cl)ccc2[nH]1)CCC3,5100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL497,Oc1c(I)cc(Cl)c2cccnc12,9800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,Bioorg Med Chem Lett,2021
CHEMBL32749,COc1cc(/C=C/C(=O)O)ccc1O,226230,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4864402,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,24600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4860315,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,39270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4848839,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,34930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL68672,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,119160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4876981,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,12380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4878181,COc1cc(/C=C/C(=O)N(C)OC)ccc1OCc1ccccc1,79870,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4847323,COc1cc(/C=C/C(=O)N2CC(F)(F)C2)ccc1OCc1ccccc1,106820,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4849442,COc1cc(/C=C/C(=O)N2CCCC2)ccc1OCc1ccccc1,65090,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4862182,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,27940,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3850,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4846673,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,10640,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4873786,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,18650,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4867164,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,45780,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL1511811,COc1cc(/C=C/C(=O)N2CCOCC2)ccc1OCc1ccccc1,78070,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4846812,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,17080,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4878858,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,18720,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4868950,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,17750,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4856483,COc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,19240,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4877271,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,16830,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4877129,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,8590,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4877193,CCN(CC)C(=O)C1CN(C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)C1,12780,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4876605,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CC(F)(F)C3)C2)ccc1OCc1ccccc1,21830,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4868565,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCCCC3)C2)ccc1OCc1ccccc1,10550,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4874507,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCOCC3)C2)ccc1OCc1ccccc1,35670,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4850421,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,3130,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4872439,COc1cc(/C=C/C(=O)NCCC(=O)N2CCCCC2)ccc1OCc1ccccc1,8170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4869616,COc1cc(/C=C/C(=O)NCCC(=O)NCc2ccccc2)ccc1OCc1ccccc1,81560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4849121,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccc(F)cc3)C2)ccc1OCc1ccccc1,3350,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4863966,COc1ccc(CNC(=O)C2CN(C(=O)/C=C/c3ccc(OCc4ccccc4)c(OC)c3)C2)cc1,4780,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4859895,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccco3)C2)ccc1OCc1ccccc1,3610,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4863296,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,1800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4876813,COc1ccc(CNC(=O)CCNC(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,54210,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4863014,COc1cc(/C=C/C(=O)NCCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,17910,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4846539,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,98460,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4872213,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,7760,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4845958,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,9910,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4458591,CCN(CC)C(=O)/C=C/c1ccc(O)c(OC)c1,205460,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4865997,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,10640,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4850411,CCCN(CCC)C(=O)/C=C/c1ccc(O)c(OC)c1,98790,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4873939,CCCN(CCC)C(=O)/C=C/c1ccc(OC)c(OC)c1,45310,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,Bioorg Med Chem,2021
CHEMBL4868743,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,2240,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4852639,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,3260,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4862604,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,4120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4876778,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,5540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4857779,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,3950,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4848375,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,4510,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4870117,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,7010,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4859825,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,6260,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4856094,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,3290,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4846443,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,2570,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4872910,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,5320,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4848524,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,6020,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4853496,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,5380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4852674,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,6180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4876429,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,2070,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4878762,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,3050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4287929,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7120,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,8270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2021
CHEMBL4863690,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,3560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4873761,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1480,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4854597,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1490,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4861145,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4865817,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,880,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4876641,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1030,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4857021,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1320,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4858987,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,2100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4874405,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4854252,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,1680,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4850978,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3780,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4872327,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,Eur J Med Chem,2021
CHEMBL4878996,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,4600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 24 hrs by thioflavin-T fluorescence method,Bioorg Med Chem Lett,2021
CHEMBL4850080,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,53010,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4860892,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,68500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4879194,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,41160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4861569,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,21920,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4871443,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,41150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4877793,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,137390,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4846727,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,113130,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4848103,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,47810,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4852897,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,167530,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4848555,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,115520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4867846,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,136390,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4850077,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,117490,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4851224,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,55950,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4863425,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,82410,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4850840,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,102590,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4870723,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,6560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4874275,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,70480,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4864237,O=C(O)c1ccc(F)cc1NCc1ccco1,129540,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4858866,O=C(O)c1ccc(Br)cc1NCc1ccco1,154420,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4858198,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,153050,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4848389,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,129690,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,Eur J Med Chem,2021
CHEMBL4846102,O=c1c2cc(NCc3ccccc3O)ccc2nc2n1CCC2,4690,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4871074,O=c1c2cc(NCc3cccc(Br)c3O)ccc2nc2n1CCC2,8340,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4876164,O=c1c2cc(NCc3ccc(Cl)cc3O)ccc2nc2n1CCC2,7020,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4874834,COc1cccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c1O,4200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4871454,O=c1c2cc(NCc3cc(Br)ccc3O)ccc2nc2n1CCC2,7630,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4861468,O=c1c2cc(NCc3cc(F)ccc3O)ccc2nc2n1CCC2,6300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4852660,COc1ccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c(O)c1,3910,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4849288,Cc1cc2nc3n(c(=O)c2cc1NCc1ccccc1O)CCC3,5090,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4879281,Cc1cc2nc3n(c(=O)c2cc1NCc1cccc(Br)c1O)CCC3,9270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4875354,Cc1cc2nc3n(c(=O)c2cc1NCc1ccc(Cl)cc1O)CCC3,6100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4870217,COc1cccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c1O,4260,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4853059,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(Br)ccc1O)CCC3,7370,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4856085,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(F)ccc1O)CCC3,6330,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4860689,COc1ccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c(O)c1,3220,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL497,Oc1c(I)cc(Cl)c2cccnc12,9800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,Bioorg Med Chem,2021
CHEMBL4845912,COc1c(O)c(O)c(C(=O)O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,6600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL4847749,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CCCC2=C/C(=C\C(C)(C)O)OC2=O)c1O,40700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL4846858,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CCCC1=C/C(=C\C(C)(C)O)OC1=O,51400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL4871044,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CC/C=C(\C)CC[C@H](O)C(C)(C)O,53300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL487804,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL513978,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL4877566,COC(=O)c1c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c1O,50300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL164,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,9900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL378225,C[C@@H](NC(=O)c1cc(C(=O)N[C@@H](Cc2ccccc2)[C@H](O)CNC2CC2)cc(N(C)S(C)(=O)=O)c1)c1ccccc1,100000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,J Nat Prod,2021
CHEMBL4850546,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,Eur J Med Chem,2021
CHEMBL4845823,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,1380,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,Eur J Med Chem,2021
CHEMBL1091513,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Active,Aβ42 inhibition assay,,2021
CHEMBL1091513,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Active,Aβ40 inhibition assay,,2021
CHEMBL1091513,O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F,0.65,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Active,Radioligand Binding Assay,,2021
CHEMBL4558518,CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,1600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Not Active,Aβ40 inhibition assay,,2021
CHEMBL3609749,COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,31,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Active,Aβ42 inhibition assay,,2021
CHEMBL3609749,COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1,131,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Active,Aβ40 inhibition assay,,2021
CHEMBL4752561,COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Not Active,Aβ42 inhibition assay,,2021
CHEMBL4752561,COc1cc(-c2cn([C@H]3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,Not Active,Aβ40 inhibition assay,,2021
CHEMBL2152899,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5085521,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2cc(C#N)nc2C(N)=N1,8.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5088449,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,12.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5075933,C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5073381,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4c(C#N)cnc4C(N)=N3)c2)cn1,6.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5084378,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5085412,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5093303,C[C@@]1(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5093195,Cc1nc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)co1,4.8,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5077699,C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5082406,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.2,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL5074068,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1,1.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,ACS Med Chem Lett,2022
CHEMBL3261067,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,98,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3261069,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3261068,Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1,98,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670365,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670368,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670371,C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670372,C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,10,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670375,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL5070669,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,30,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670385,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,26,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670367,C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,284,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL5089745,C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,263,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL5080033,COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1,23,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3670375,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta42 level,J Med Chem,2021
CHEMBL3670375,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta40 level,J Med Chem,2021
CHEMBL3670375,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta(1 to 40 residues) level,J Med Chem,2021
CHEMBL5093426,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CCSC(N)=N1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of APP751 (unknown origin) expressed in CHO cells,J Med Chem,2021
CHEMBL3261067,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP expressed in CHO cells assessed as reduction in soluble APP beta level incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653341,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653393,CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL4128145,C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N,1160,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653399,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1,32,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653404,C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653403,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653405,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3261067,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5077684,Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,105,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5073160,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5090563,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5075177,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1,17,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5086270,Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,6,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5074449,C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL5085959,C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653401,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3653401,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3261067,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 40 secretion incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL3261067,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 42 secretion incubated for 24 hrs by immunoassay,J Med Chem,2021
CHEMBL231160,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-aggregation of amyloid beta (1 to 42) (unknown origin) by thioflavin T method,Eur J Med Chem,2022
CHEMBL231160,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,28300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of human AChE-induced amyloid beta (1 to 40) aggregation (unknown origin),Eur J Med Chem,2022
CHEMBL1642177,COc1cc(/C=C/c2nc3cc(Cl)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,660,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells,Eur J Med Chem,2022
CHEMBL1642177,COc1cc(/C=C/c2nc3cc(Cl)ccc3c(=O)[nH]2)ccc1-n1cnc(C)c1,10000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 1 to 40 aggregation in human SH-SY5Y cells,Eur J Med Chem,2022
CHEMBL5208951,COc1cc2c(Nc3ccc(C(=O)/C=C/c4nc(C)c(C)nc4C)cc3)ncnc2c(OC)c1OC,26700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 1 to 42 (unknown origin) at 10 uM relative to control,Eur J Med Chem,2022
CHEMBL5192892,COc1nc(-c2cc(C)c(N[C@@H](C)c3cc(F)cc(F)c3)nn2)ccc1-n1cnc(C)c1,4.1,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) secretion,Eur J Med Chem,2022
CHEMBL5206552,COc1nc(-c2cc(C)c(N[C@@H](C)c3cc(F)c(F)c(F)c3)nn2)ccc1-n1cnc(C)c1,5.3,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) secretion,Eur J Med Chem,2022
CHEMBL5199489,Clc1ccc(/C=N/c2ccc3cn[nH]c3c2)cc1Cl,19500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-treated Amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 46 to 48 hrs by fluorescence based assay,Eur J Med Chem,2022
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,17900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-treated Amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 46 to 48 hrs by fluorescence based assay,Eur J Med Chem,2022
CHEMBL5200462,O=c1cc(/N=N/N=P(CCP(=N/N=N/c2cc(=O)oc3ccccc23)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)c2ccccc2o1,337770,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin T based fluorometric assay,Bioorg Med Chem,2022
CHEMBL5209357,Cc1nc(C)c(C(=O)OCCCOC(=O)c2ccccn2)nc1C,49140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2022
CHEMBL5196827,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,9260,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2022
CHEMBL5208803,CCOC(=O)C(Cc1cn(-c2ccccc2)nn1)(Cc1cn(-c2ccccc2)nn1)NC(C)=O,8065,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,Bioorg Med Chem,2022
CHEMBL5200867,CCCSC(=O)/C=C/c1ccc(O)c(O)c1,3990,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,ACS Med Chem Lett,2022
CHEMBL5198252,CCCSC(=O)/C=C/c1cc(O)ccc1O,10200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,ACS Med Chem Lett,2022
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) incubated for 7 days by sandwich ELISA,Eur J Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 (unknown origin) assessed as disaggregation of fibrillar amyloid beta 40 incubated for 3 days by ELISA assay,Eur J Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,107,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL181529,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,138,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5174150,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)OC(C)(C)C)c(OC)c3)on2)ccc1OCC(=O)OC(C)(C)C,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5195740,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)O)c(OC)c3)on2)ccc1OCC(=O)O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL180239,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,476,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5209194,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(Cc3ccccc3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL258741,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccccc3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5189854,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc([N+](=O)[O-])cc3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5200280,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(Cl)nn3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5176644,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C)cc3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5175279,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C(C)C)cc3)n2)ccc1O,1000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL181529,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,7400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5174150,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)OC(C)(C)C)c(OC)c3)on2)ccc1OCC(=O)OC(C)(C)C,40000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5195740,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)O)c(OC)c3)on2)ccc1OCC(=O)O,14100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL180239,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,9700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5209194,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(Cc3ccccc3)n2)ccc1O,11500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL258741,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccccc3)n2)ccc1O,11300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5189854,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc([N+](=O)[O-])cc3)n2)ccc1O,6200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5200280,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(Cl)nn3)n2)ccc1O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5176644,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C)cc3)n2)ccc1O,8700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5175279,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C(C)C)cc3)n2)ccc1O,6900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL492807,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(C)n2)ccc1O,10400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5205561,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(CCO)n2)ccc1O,17800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL258632,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3cccc([N+](=O)[O-])c3)n2)ccc1O,15100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5183237,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3cc(Cl)cc(Cl)c3)n2)ccc1O,6300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL181529,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,6800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5174150,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)OC(C)(C)C)c(OC)c3)on2)ccc1OCC(=O)OC(C)(C)C,40000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5195740,COc1cc(/C=C/c2cc(/C=C/c3ccc(OCC(=O)O)c(OC)c3)on2)ccc1OCC(=O)O,40000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL180239,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)[nH]n2)ccc1O,8700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5209194,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(Cc3ccccc3)n2)ccc1O,15300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL258741,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccccc3)n2)ccc1O,14200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5189854,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc([N+](=O)[O-])cc3)n2)ccc1O,3500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5200280,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(Cl)nn3)n2)ccc1O,4800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5176644,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C)cc3)n2)ccc1O,5000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5175279,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3ccc(C(C)C)cc3)n2)ccc1O,4400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL492807,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(C)n2)ccc1O,9000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5205561,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(CCO)n2)ccc1O,17300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL258632,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3cccc([N+](=O)[O-])c3)n2)ccc1O,14200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5183237,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)n(-c3cc(Cl)cc(Cl)c3)n2)ccc1O,3500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 secretion transfected in human H4 cells incubated for 20 to 24 hrs by LPECL assay,Eur J Med Chem,2021
CHEMBL5174183,O=C(CN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12,5671,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5194732,O=C(CCN1CCOCC1)Nc1n[nH]c2ncccc12,2126,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5199487,O=C(CCN1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2ncccc12,13270,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5183077,O=C(CCN1CCN(c2ccccc2)CC1)Nc1n[nH]c2ncccc12,1979,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5197114,Cc1ccc2nc3c(c(N4CCCCC4)c2c1)CCCC3,6696,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5172647,COc1cc2nc3c(c(N4CCOCC4)c2cc1OC)CCCC3,1227,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5199361,CN1CCN(c2c3c(nc4ccc([N+](=O)[O-])cc24)CCCC3)CC1,4494,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5174252,O=[N+]([O-])c1ccc2nc3c(c(Nc4[nH]nc5ncccc45)c2c1)CCCC3,777,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5205489,Nc1nn(-c2c3c(nc4ccc([N+](=O)[O-])cc24)CCCC3)c2ncccc12,31760,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5190530,Cc1ccc2nc3c(c(NCCO)c2c1)CCCC3,2954,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5199187,Cc1ccc2nc3c(c(NCCN4CCOCC4)c2c1)CCCC3,15040,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL5185354,CC(=O)Nc1ccc2nc3c(c(N4CCCCC4)c2c1)CCCC3,1303,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 3 hrs by ThT fluorescence assay,Eur J Med Chem,2022
CHEMBL88041,CCN(CC)CCCOc1ccc(-c2oc3ccccc3c2C(=O)c2ccc(C)cc2)cc1,56000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation,J Med Chem,2021
CHEMBL5289089,Cc1c(O)c(=O)ccn1-c1ccc(OCCCN2CCCC2)cc1,2850,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation,J Med Chem,2021
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,13150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of HFIP-pretreated human amyloid beta (1 to 42) aggregation incubated for 24 hrs under dark condition by Thioflavin T dye based fluorometric analysis,RSC Med Chem,2023
CHEMBL5286134,O=[N+]([O-])c1ccc(-c2cccc(C(O)C(F)(F)F)c2)cc1N1CCCC1,6650,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta40 (unknown origin) aggregation measured every 15 mins by fluorescence based analysis,J Med Chem,2021
CHEMBL5289429,O=[N+]([O-])c1ccc(-c2cccc(C(O)C(F)(F)F)c2)cc1NCc1ccccc1,3090,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta40 (unknown origin) aggregation measured every 15 mins by fluorescence based analysis,J Med Chem,2021
CHEMBL5281113,CC(O)c1cccc(-c2ccc([N+](=O)[O-])c(NCc3ccccc3)c2)c1,6490,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta40 (unknown origin) aggregation measured every 15 mins by fluorescence based analysis,J Med Chem,2021
CHEMBL5289087,CC(C)(C)c1ccc(-c2cc(N3CC(CN4CCCC4)C3)c3nonc3c2)cc1,620,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (unknown origin),J Med Chem,2021
CHEMBL5285691,c1ccc(Oc2ccc(-c3cc(N4CC(CN5CCCC5)C4)c4nonc4c3)cc2)cc1,520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (unknown origin),J Med Chem,2021
CHEMBL5282290,OC(c1ccc(-c2cc(N3CC(CN4CCCC4)C3)c3nonc3c2)s1)C(F)(F)F,1100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (unknown origin),J Med Chem,2021
CHEMBL5283208,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc([N+](=O)[O-])cc1)C2,1800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation by ThT-based fluorometric assay,J Med Chem,2022
CHEMBL5283208,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc([N+](=O)[O-])cc1)C2,7900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) disaggregation by ThT-based fluorometric assay,J Med Chem,2022
CHEMBL5287571,CCC(=O)O[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42 ) (unknown origin),J Med Chem,2021
CHEMBL5276202,Cl.Oc1cccc2ccc(/C=C/C3=CCN(Cc4ccccc4C(F)(F)F)CC3)nc12,1655000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of AChE induced HFIP-pretreated amyloid beta (1 to 42 ) (unknown origin) aggregation incubated for 24 hr by Thioflavin T based fluorometric assay,Eur J Med Chem,2022
CHEMBL502,COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,1593000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of AChE induced HFIP-pretreated amyloid beta (1 to 42 ) (unknown origin) aggregation incubated for 24 hr by Thioflavin T based fluorometric assay,Eur J Med Chem,2022
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,2400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation incubated for 1 hr by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL312163,COc1cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc2c1,2300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation incubated for 1 hr by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL28626,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,7400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation incubated for 1 hr by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL31574,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12,12500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) fibril formation incubated for 1 hr by thioflavin-T fluorescence assay,Eur J Med Chem,2018
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation,Eur J Med Chem,2018
CHEMBL583912,Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,5300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation,Eur J Med Chem,2018
CHEMBL126142,O=C(O[C@H]1Cc2c(O)cc(O)cc2O[C@H]1c1ccc(O)c(O)c1)c1cc(O)c(O)c(O)c1,3000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (unknown origin) aggregation,Eur J Med Chem,2018
CHEMBL5286183,Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,840,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (unknown origin) aggregation,Eur J Med Chem,2018
CHEMBL5290033,Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3oc12,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of self-induced amyloid beta (unknown origin) aggregation,Eur J Med Chem,2018
CHEMBL5283881,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)C[C@@H](Cc1ccccc1)C(N)=O,48,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 (unknown origin),Eur J Med Chem,2018
CHEMBL5283881,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)C(=O)C[C@@H](Cc1ccccc1)C(N)=O,67,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin),Eur J Med Chem,2018
CHEMBL297453,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5276533,COc1cc(O)cc(C(=O)O)c1C(=O)c1c(O)cc(CO)cc1O,1070,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5268526,COC(=O)c1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc(OC)c1C(=O)c1c(O)cc(C)cc1O,4730,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5283758,COC(=O)c1cc(O[C@@H]2O[C@H](COC(=O)CCC(=O)O)[C@@H](O)[C@H](O)[C@H]2O)cc(OC)c1C(=O)c1c(O)cc(C)cc1O,3010,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5274298,COC(=O)c1cc(O)cc(OC)c1C(=O)c1c(O)cc(CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1O,1030,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5283067,COC(=O)c1c(Sc2c(O)cc(OC)c(C(=O)c3c(O)cc(C)cc3O)c2C(=O)OC)c(O)cc(OC)c1C(=O)c1c(O)cccc1O,990,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5273520,COC(=O)c1c(O)cc(C)c(Sc2c(O)cc(OC)c(Oc3c(O)cc(C)cc3O)c2O)c1C(=O)c1c(O)cc(C)cc1O,100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5282081,COC(=O)c1c(O)cc(C)cc1C(=O)c1cc(O)cc2oc3cc4c(c(O)c3c12)C(=O)c1c(O)cc(C)cc1C4=O,1560,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5274654,Cc1cc(O)c(C(=O)c2c(O)cc3c(c2O)C(=O)c2c(O)cc(C)cc2C3=O)c(C(=O)c2cc(O)c(O)cc2O)c1,180,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThioflavinT-dye based fluorescence analysis,J Nat Prod,2023
CHEMBL5410783,O=c1ccoc(/C=C/c2ccc([N+](=O)[O-])cc2)c1O,38150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5412178,CN(C)c1ccc(/C=C/c2occc(=O)c2O)cc1,47150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5413248,O=c1ccoc(/C=C/c2ccc(N3CCCCC3)cc2)c1O,33430,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5431087,O=c1ccoc(/C=C/c2ccc(N3CCOCC3)cc2)c1O,49370,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5434040,O=c1ccoc(/C=C/c2ccc(N3CCSCC3)cc2)c1O,46750,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5419566,COc1ccc(/C=C/c2occc(=O)c2O)cc1O,43730,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5412904,O=c1ccoc(/C=C/c2ccc(O)c(O)c2)c1O,11150,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15990,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,Eur J Med Chem,2023
CHEMBL5410783,O=c1ccoc(/C=C/c2ccc([N+](=O)[O-])cc2)c1O,26290,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5412178,CN(C)c1ccc(/C=C/c2occc(=O)c2O)cc1,42410,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5413248,O=c1ccoc(/C=C/c2ccc(N3CCCCC3)cc2)c1O,27200,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5431087,O=c1ccoc(/C=C/c2ccc(N3CCOCC3)cc2)c1O,23930,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5434040,O=c1ccoc(/C=C/c2ccc(N3CCSCC3)cc2)c1O,28470,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5419566,COc1ccc(/C=C/c2occc(=O)c2O)cc1O,43170,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5412904,O=c1ccoc(/C=C/c2ccc(O)c(O)c2)c1O,6870,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,9620,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation assessed as disaggregation,Eur J Med Chem,2023
CHEMBL5412904,O=c1ccoc(/C=C/c2ccc(O)c(O)c2)c1O,3690,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Cu2+ induced of amyloid beta (1 to 42) aggregation (unknown origin),Eur J Med Chem,2023
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,9140,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Cu2+ induced of amyloid beta (1 to 42) aggregation (unknown origin),Eur J Med Chem,2023
CHEMBL5412904,O=c1ccoc(/C=C/c2ccc(O)c(O)c2)c1O,9680,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Fe3+ induced of amyloid beta (1 to 42) aggregation (unknown origin),Eur J Med Chem,2023
CHEMBL165,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,20730,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of Fe3+ induced of amyloid beta (1 to 42) aggregation (unknown origin),Eur J Med Chem,2023
CHEMBL3352860,Cc1ccc(NC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,28000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5286183,Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,840,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5427593,Cc1ccc(NCCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,4300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5422760,Cc1ccc(NCCCSC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,4300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5408406,Cc1ccc(NC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3cc(O)ccc3sc12,5900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5431870,Cc1ccc(NCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3cc(O)ccc3sc12,2400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5434938,Cc1ccc(NCCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3cc(O)ccc3sc12,2900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5406305,COc1ccc2sc3c(C)ccc(NC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,4300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5419364,COc1ccc2sc3c(C)ccc(NCC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,2400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5425075,COc1ccc2sc3c(C)ccc(NCCC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,2500,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5434315,O=c1c2ccccc2sc2c([N+](=O)[O-])ccc(NC[C@@H]3CCCN4CCCC[C@H]34)c12,20000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5397772,O=c1c2ccccc2sc2c([N+](=O)[O-])ccc(NCCC[C@@H]3CCCN4CCCC[C@H]34)c12,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5395840,COc1ccc2sc3c([N+](=O)[O-])ccc(NC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,11000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5415210,COc1ccc2sc3c([N+](=O)[O-])ccc(NCC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,9100,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5405496,COc1ccc2sc3c([N+](=O)[O-])ccc(NCCC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,7900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5401774,Nc1ccc(NC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,14000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5422668,Nc1ccc(NCCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3sc12,1300,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5436261,COc1ccc2sc3c(N)ccc(NCC[C@@H]4CCCN5CCCC[C@H]45)c3c(=O)c2c1,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL279014,CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12,24000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5439128,CCN(CC)CCCNc1ccc([N+](=O)[O-])c2sc3ccc(OC)cc3c(=O)c12,17000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5418214,CCN(CC)CCCNc1ccc(N)c2sc3ccc(OC)cc3c(=O)c12,21000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5409312,Cc1ccc(NC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3oc12,48000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5438801,Cc1ccc(NCCC[C@@H]2CCCN3CCCC[C@H]23)c2c(=O)c3ccccc3oc12,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,820,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5415164,CCCN(SC[C@H]1CCCN2CCCC[C@H]12)C1=C(Cl)C(=O)c2ccccc2C1=O,61000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 peptide (unknown origin) aggregation incubated for 2 hr by ThT fluorescence based spectrofluorimetric analysis,Eur J Med Chem,2023
CHEMBL5408201,Cl.O=C(NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2)c1nc2ccc([N+](=O)[O-])cc2s1,3800,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) self aggregation incubated for 48 hrs by fluoroMax-4 spectrofluorometeric analysis,Eur J Med Chem,2022
CHEMBL5425561,COc1cc2c(cc1OC)-c1c(-c3ccc(Cl)cc3)c(/C=N/c3ccc(/N=C/c4cn5c(c4-c4ccc(Cl)cc4)-c4cc(OC)c(OC)cc4CC5)cc3)cn1CC2,13000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 40 (unknown origin) aggregation for 2 hrs by ThT fluoroscence assay,Eur J Med Chem,2022
CHEMBL5396832,CC(C)[C@H](Nc1c(NC[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)c(=O)c1=O)C(=O)O,7710,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin) aggregation at 1:10 compound:amyloidbeta ratio incubated for 24 hrs by ThT fluorescence assay,Bioorg Med Chem,2024
CHEMBL5409325,C[C@H](O)[C@H](Nc1c(NC[C@H](Cc2ccccc2)NC(=O)OC(C)(C)C)c(=O)c1=O)C(=O)O,8080,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin) aggregation at 1:10 compound:amyloidbeta ratio incubated for 24 hrs by ThT fluorescence assay,Bioorg Med Chem,2024
CHEMBL5436582,CC(C)(C)OC(=O)N[C@H](CNc1c(N[C@@H](CC(N)=O)C(=O)O)c(=O)c1=O)Cc1ccccc1,17520,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin) aggregation at 1:10 compound:amyloidbeta ratio incubated for 24 hrs by ThT fluorescence assay,Bioorg Med Chem,2024
CHEMBL5434119,CC(C)(C)OC(=O)N[C@H](CNc1c(N[C@@H](Cc2ccccc2)C(=O)O)c(=O)c1=O)Cc1ccccc1,14600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin) aggregation at 1:10 compound:amyloidbeta ratio incubated for 24 hrs by ThT fluorescence assay,Bioorg Med Chem,2024
CHEMBL3950384,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,420,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin),RSC Med Chem,2023
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid-beta (unknown origin),RSC Med Chem,2023
CHEMBL5430188,O=C1C(=O)N2CCc3cc4c(c5c3c2c1c1ccccc15)OCO4,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5404812,COc1ccc2c(c1OC)c1c3c4c(cc5c(c42)OCO5)CCN3C(=O)C1=O,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5427350,COc1cc(O)cc2c1-c1c3c(cc4c1[C@@H](C2)N(C)CC4)OCO3,35700,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5411734,COc1cc(O)c2c(c1)C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL452201,COc1ccc2c(c1)C[C@H]1NCCc3cc4c(c-2c31)OCO4,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5416128,COc1cc(O)c2c(c1)C[C@H]1NCCc3cc4c(c-2c31)OCO4,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5408625,COc1cc(O)c2c(c1)C[C@H]1NCCc3c(OC)c4c(c-2c31)OCO4,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL510954,COc1ccc2c(c1)C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5427951,COc1cc(O)c2c(c1)C[C@@H]1c3c(cc4c(c3-2)OCO4)CC[N@+]1(C)[O-],50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5415340,COc1cc(O)c2c(c1)C[C@@H]1c3c(cc4c(c3-2)OCO4)CC[N@@+]1(C)[O-],50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5435367,COC1=CC(=O)c2c(cc3c4c(cc5c(c24)OCO5)CCN3C)C1=O,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL389400,COc1ccc2c(c1)C(=O)c1nccc3cc4c(c-2c13)OCO4,31900,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5414196,COc1ccc(C[C@H]2c3c(ccc(OC)c3O)CCN2C)cc1,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL448891,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL1235966,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5434024,COc1cc2c(cc1O)CC[n+]1cc3c(OC)c(O)ccc3cc1-2,50000,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL5411138,COC1=C(CC(=O)CCc2ccccc2)C(=O)O[C@@H]1O,26600,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
CHEMBL140,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,24400,nM,IC50,Amyloid-beta A4 protein,Homo sapiens,,Inhibition of amyloid beta 42 (unknown origin) aggregation incubated for 24 hrs by ThT assay,J Nat Prod,2023
